bpc 157 benefits risks clinical studies Peptide BPC-157 BPC-157: Miracle Healing Peptide or

It is relevant to note that, in patients with upper gastrointestinal symptoms, there are about 25% of patients with delayed gastric emptying, about 25% with impaired gastric accommodation, and about 25% with the combination of both gastric motor dysfunctions ( In this article, new developments in prokinetic therapy for these motility disorders are reviewed

It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form

And few if any side effects have been documented in the scientific literature

Prior to the development of targeted peptides such as BPC-157 and TB-500, research into tissue healing and recovery relied largely on broad growth factors and nonspecific biochemical interventions